NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -20.0% | 218 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | -99.6% | 218 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $1,120,000 | -56.0% | 61,467 | -14.2% | 0.00% | 0.0% |
| Q2 2019 | $2,547,000 | -23.4% | 71,604 | -27.7% | 0.00% | -60.0% |
| Q1 2019 | $3,325,000 | -64.8% | 98,991 | -65.6% | 0.01% | -44.4% |
| Q4 2018 | $9,455,000 | -46.1% | 287,663 | -0.0% | 0.01% | -60.9% |
| Q3 2018 | $17,538,000 | +27.6% | 287,704 | +2.2% | 0.02% | +15.0% |
| Q2 2018 | $13,747,000 | -25.1% | 281,528 | +63.0% | 0.02% | -31.0% |
| Q1 2018 | $18,350,000 | +62.5% | 172,684 | -8.7% | 0.03% | +70.6% |
| Q4 2017 | $11,293,000 | – | 189,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |